首页 > 最新文献

Journal of insurance medicine (New York, N.Y.)最新文献

英文 中文
Déjà Vu - A New Coronavirus Challenge. Déjà Vu - 新的冠状病毒挑战。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.17849/insm-49-1-5-10.1
Ross MacKenzie
{"title":"Déjà Vu - A New Coronavirus Challenge.","authors":"Ross MacKenzie","doi":"10.17849/insm-49-1-5-10.1","DOIUrl":"https://doi.org/10.17849/insm-49-1-5-10.1","url":null,"abstract":"","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38886806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long COVID - An Early Perspective. 长期COVID -早期视角。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.17849/insm-49-1-1-5.1
Timothy Meagher

A new syndrome called "Long COVID" has emerged amongst the survivors of acute COVID-19 infection. Its protracted and debilitating nature will almost certainly result in many short and long-term disability claims. Insurers need to understand the nature of Long COVID, including its definition, its prevalence, its natural history, and underlying risk factors. This article will summarize current knowledge of Long COVID and provide a perspective on its evolution and its impact.

在急性COVID-19感染的幸存者中出现了一种名为“长COVID”的新综合征。它的长期性和衰弱性几乎肯定会导致许多短期和长期残疾索赔。保险公司需要了解长冠状病毒的本质,包括其定义、流行程度、自然历史和潜在风险因素。本文将总结当前关于Long COVID的知识,并就其演变及其影响提供一个视角。
{"title":"Long COVID - An Early Perspective.","authors":"Timothy Meagher","doi":"10.17849/insm-49-1-1-5.1","DOIUrl":"https://doi.org/10.17849/insm-49-1-1-5.1","url":null,"abstract":"<p><p>A new syndrome called \"Long COVID\" has emerged amongst the survivors of acute COVID-19 infection. Its protracted and debilitating nature will almost certainly result in many short and long-term disability claims. Insurers need to understand the nature of Long COVID, including its definition, its prevalence, its natural history, and underlying risk factors. This article will summarize current knowledge of Long COVID and provide a perspective on its evolution and its impact.</p>","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25542034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Type 2 Diabetes in China - Considering Both Insurance Products and Individual Health Factors. 中国的 2 型糖尿病--同时考虑保险产品和个人健康因素。
Q3 Medicine Pub Date : 2020-06-10 DOI: 10.17849/insm-48-2-1-5.1
Celia Zhang Ying

For the past 30 years, the increase in the prevalence of type 2 diabetes mellitus (T2DM) in China has reached epidemic proportions. As a result, risk assessment guidelines need to be updated by taking into consideration of improvements in medical treatment and lifestyle intervention. This especially applies to living insurance benefit policies (such as critical illness and total permanent disability) and to medical products (hospitalization reimbursement and certain DM-related treatment benefits). This will require taking into account the current epidemic figures of T2DM in China in pricing, targeting the correct insured group for the DM products and getting the correct risk profile by applying a dynamic underwriting protocol (such as using the rewards for medical intervention, and for primary prevention efforts to screen individuals who are at high-risk of diabetes). This article analyzes both studies and surveys that been conducted in China showing the progress of this epidemic.

近 30 年来,中国 2 型糖尿病(T2DM)患病率的增长已达到流行病的程度。因此,风险评估指南需要根据医疗和生活方式干预方面的改进进行更新。这尤其适用于生活保险给付(如重大疾病和永久性全残)和医疗产品(住院报销和某些与糖尿病相关的治疗给付)。这就需要在定价时考虑到 T2DM 目前在中国的流行情况,为 DM 产品锁定正确的投保群体,并通过采用动态核保方案(如将奖励用于医疗干预和初级预防工作,以筛查糖尿病高危人群)来获得正确的风险状况。本文分析了在中国开展的研究和调查,这些研究和调查显示了这一流行病的进展情况。
{"title":"Type 2 Diabetes in China - Considering Both Insurance Products and Individual Health Factors.","authors":"Celia Zhang Ying","doi":"10.17849/insm-48-2-1-5.1","DOIUrl":"10.17849/insm-48-2-1-5.1","url":null,"abstract":"<p><p>For the past 30 years, the increase in the prevalence of type 2 diabetes mellitus (T2DM) in China has reached epidemic proportions. As a result, risk assessment guidelines need to be updated by taking into consideration of improvements in medical treatment and lifestyle intervention. This especially applies to living insurance benefit policies (such as critical illness and total permanent disability) and to medical products (hospitalization reimbursement and certain DM-related treatment benefits). This will require taking into account the current epidemic figures of T2DM in China in pricing, targeting the correct insured group for the DM products and getting the correct risk profile by applying a dynamic underwriting protocol (such as using the rewards for medical intervention, and for primary prevention efforts to screen individuals who are at high-risk of diabetes). This article analyzes both studies and surveys that been conducted in China showing the progress of this epidemic.</p>","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38032792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Activity Level as a Mortality Predictor in a Population Sample after Typical Underwriting Exclusions and Laboratory Scoring. 活动水平作为典型核保排除和实验室评分后人口样本的死亡率预测指标。
Q3 Medicine Pub Date : 2020-04-30 DOI: 10.17849/insm-48-2-1-12.1
Steven J Rigatti, Robert Stout

Objectives.- To quantify the effect of physical activity on the mortality rates of healthy individuals in a population sample, after controlling for other sources of mortality risk. Background.- The widespread availability of activity monitors has spurred life insurance companies to consider incorporating such data into their underwriting practices. Studies have shown that sedentary lifestyles are associated with poor health outcomes and higher risks of death. The aim of this paper is to investigate how well certain measures of activity predict mortality when controlled for other known predictors of mortality including a multivariate laboratory based risk score. Methods.- Data were obtained from the National Health and Nutrition Examination Survey (NHANES) for the years 1999 through 2014. Laboratory and biometric data were scored for mortality risk using a previously developed proprietary algorithm (CRL SmartScore). Data on activity were obtained from the NHANES questionnaires pertaining to activity. In a second analysis, data were obtained from pedometers worn for 1 week by NHANES participants (years 2003-2004, and 2005-2006 only). Before analysis, cases were selected based on commonly used life insurance underwriting criteria to remove from consideration those who have major health issues, which would ordinarily preclude an offer of life insurance. Results.-In fully-adjusted Cox model which included survey-based MET*hours per day as a 3-level categorical variable, the moderate and minimal levels of activity were associated with hazard ratios of 1.15 (95% CI: 1.04-1.28) and 1.38 (95% CI: 1.23-1.56), respectively, when compared to the highest level of activity. When treated as a continuous variable, the fully adjusted model the HR for MET*hours per day was 0.91 (95% CI: 0.87-0.95). In fully adjusted models using pedometer data, the percentage of wear time spent sedentary was associated with mortality (HR: 1.19, 95% CI: 1.09-1.31), while average counts per minute were negatively associated with mortality (HR: 0.82, CI: 0.75-0.90). Conclusions.-It is clear from these results that high proportions of sedentary time are associated with increased mortality, whether the sedentary time is quantified via questionnaire or pedometer. Because both laboratory scores and activity levels remain significant in Cox models where both are included, these factors are largely independent, indicating that they are measuring distinct influences on the risk of mortality.

目标--在控制了其他死亡风险来源之后,量化体育锻炼对人口样本中健康人死亡率的影响。背景--活动监测器的普及促使人寿保险公司考虑将此类数据纳入其承保实践。研究表明,久坐不动的生活方式与不良的健康状况和较高的死亡风险有关。本文旨在研究在控制其他已知死亡率预测因素(包括基于实验室的多变量风险评分)的情况下,某些活动量能在多大程度上预测死亡率。方法:数据来自 1999 年至 2014 年的美国国家健康与营养调查(NHANES)。使用之前开发的专有算法(CRL SmartScore)对实验室和生物测量数据进行死亡风险评分。活动数据来自 NHANES 有关活动的调查问卷。在第二项分析中,数据来自 NHANES 参与者佩戴一周的计步器(仅 2003-2004 年和 2005-2006 年)。在分析之前,根据常用的人寿保险承保标准对案例进行了筛选,以剔除那些有重大健康问题的人,因为这些问题通常会排除人寿保险的提供。结果......在完全调整的 Cox 模型中,将基于调查的每天 MET* 小时数作为 3 级分类变量,与最高活动水平相比,中等和最低活动水平的危险比分别为 1.15(95% CI:1.04-1.28)和 1.38(95% CI:1.23-1.56)。当作为连续变量处理时,MET*每天小时数的完全调整模型HR为0.91(95% CI:0.87-0.95)。在使用计步器数据的完全调整模型中,久坐不动的佩戴时间百分比与死亡率相关(HR:1.19,95% CI:1.09-1.31),而每分钟平均计数与死亡率呈负相关(HR:0.82,CI:0.75-0.90)。结论:这些结果清楚地表明,无论久坐时间是通过问卷还是计步器量化,久坐时间比例高都与死亡率增加有关。由于实验室评分和活动水平在同时纳入这两个因素的 Cox 模型中仍具有显著性,因此这两个因素在很大程度上是独立的,这表明它们测量的是对死亡风险的不同影响因素。
{"title":"Activity Level as a Mortality Predictor in a Population Sample after Typical Underwriting Exclusions and Laboratory Scoring.","authors":"Steven J Rigatti, Robert Stout","doi":"10.17849/insm-48-2-1-12.1","DOIUrl":"10.17849/insm-48-2-1-12.1","url":null,"abstract":"<p><p>  <b>Objectives.-</b> To quantify the effect of physical activity on the mortality rates of healthy individuals in a population sample, after controlling for other sources of mortality risk. <b>Background.-</b> The widespread availability of activity monitors has spurred life insurance companies to consider incorporating such data into their underwriting practices. Studies have shown that sedentary lifestyles are associated with poor health outcomes and higher risks of death. The aim of this paper is to investigate how well certain measures of activity predict mortality when controlled for other known predictors of mortality including a multivariate laboratory based risk score. <b>Methods.-</b> Data were obtained from the National Health and Nutrition Examination Survey (NHANES) for the years 1999 through 2014. Laboratory and biometric data were scored for mortality risk using a previously developed proprietary algorithm (CRL SmartScore). Data on activity were obtained from the NHANES questionnaires pertaining to activity. In a second analysis, data were obtained from pedometers worn for 1 week by NHANES participants (years 2003-2004, and 2005-2006 only). Before analysis, cases were selected based on commonly used life insurance underwriting criteria to remove from consideration those who have major health issues, which would ordinarily preclude an offer of life insurance. <b>Results.-</b>In fully-adjusted Cox model which included survey-based MET*hours per day as a 3-level categorical variable, the moderate and minimal levels of activity were associated with hazard ratios of 1.15 (95% CI: 1.04-1.28) and 1.38 (95% CI: 1.23-1.56), respectively, when compared to the highest level of activity. When treated as a continuous variable, the fully adjusted model the HR for MET*hours per day was 0.91 (95% CI: 0.87-0.95). In fully adjusted models using pedometer data, the percentage of wear time spent sedentary was associated with mortality (HR: 1.19, 95% CI: 1.09-1.31), while average counts per minute were negatively associated with mortality (HR: 0.82, CI: 0.75-0.90). <b>Conclusions.-</b>It is clear from these results that high proportions of sedentary time are associated with increased mortality, whether the sedentary time is quantified via questionnaire or pedometer. Because both laboratory scores and activity levels remain significant in Cox models where both are included, these factors are largely independent, indicating that they are measuring distinct influences on the risk of mortality.</p>","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37887984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's in a name? 名字里有什么?
Q3 Medicine Pub Date : 2020-04-17 DOI: 10.1201/b17764-12
N. Roberts
{"title":"What's in a name?","authors":"N. Roberts","doi":"10.1201/b17764-12","DOIUrl":"https://doi.org/10.1201/b17764-12","url":null,"abstract":"","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46417168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic Adenoma. 肝腺瘤
Q3 Medicine Pub Date : 2020-02-05 DOI: 10.17849/insm-48-2-1-1.1
David S Williams

Hepatic adenomas are rare, usually benign tumors of the liver with a small risk for bleeding and malignant transformation.

肝腺瘤很少见,通常是肝脏的良性肿瘤,出血和恶变的风险较小。
{"title":"Hepatic Adenoma.","authors":"David S Williams","doi":"10.17849/insm-48-2-1-1.1","DOIUrl":"10.17849/insm-48-2-1-1.1","url":null,"abstract":"<p><p>Hepatic adenomas are rare, usually benign tumors of the liver with a small risk for bleeding and malignant transformation.</p>","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37613055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
20-Year Comparative Survival and Mortality of Cancer of the Esophagus by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 83,658 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4) 食管癌20年生存率和死亡率比较:年龄、性别、种族、分期、分级、队列进入时间、病程和选定的ICD-O-3肿瘤表型:1973-2014年83,658例诊断病例的系统评价
Q3 Medicine Pub Date : 2020-01-01 DOI: 10.17849/insm-48-2-113-123.1
A. Milano
Objective.— To update trends in incidence, prevalence, short- and long-term survival and mortality of esophageal cancer using the statistical database of SEER*Stat 8.3.4 for diagnosis years 1973-2014 employing multiple case selection variables. Methods.— A retrospective, population-based study using nationally representative data from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) program to evaluate 83,658 cases of esophageal cancer for diagnosis years 1973-2014 comparing multiple variables of age, sex, race, stage, grade, cohort entry time-period, disease duration, and, two histologic oncotypes. Relative survival statistics were analyzed in two cohorts: 1973-1994 and 1995-2014. Survival statistics were derived from: SEER*Stat Database: Incidence – SEER 9 Regs Research Data, November 2016 Submission (1973-2014) Released April 2017 (Ref. 9). Case frequency and incidence data, derived from the SEER program, were used to design the table format and number of pages for this report. Results.— In a total of 83,658 cases of esophageal cancer in the United States for diagnosis years 1973-2014, multiple variables of age, sex, race, stage, grade, cohort entry time-period, disease duration, and, two histologic oncotypes were compared. Mean age in males was 66.5 years, females 70.1 years, both male and female 67.2 years. Greater than 85% of incidence cases occurred between ages 55-85+ years with the zenith in males at 65-69 years (59.4%) and 70-74 years (60.5%) in females. The overall annual US death rate from 1975-2014 has slightly increased from 3.69 to 3.99 per 100,000 per year, and excess mortality remains exceedingly high. Of the 83,658 invasive cases, 82.6% were clinically staged and 79.4% were histologically graded. Conclusions.— Relative frequency, incidence and time-trends, and the clinical, demographic and secular variables of age, sex, race, stage, grade, cohort-entry time-periods, and predominant clinical oncotypes were comparatively analyzed to provide a comprehensive medical-actuarial assessment of esophageal cancer survival and mortality in the 1973-2014 time-frame.
目标。——使用SEER*Stat 8.3.4的统计数据库,采用多个病例选择变量,更新1973-2014诊断年食管癌症的发病率、患病率、短期和长期生存率和死亡率趋势。方法。——一项基于人群的回顾性研究,使用美国国家癌症研究所(NCI)监测、流行病学和最终结果(SEER)计划的全国代表性数据,评估1973-2014年诊断的83658例癌症食管癌病例,比较年龄、性别、种族、阶段、等级、队列进入时间段、疾病持续时间和两种组织学肿瘤类型的多个变量。对1973-1994年和1995-2014年两个队列的相对生存率统计数据进行了分析。生存统计数据来源于:SEER*统计数据库:发病率-SEER 9 Regs研究数据,2016年11月提交(1973-2014),2017年4月发布(参考文献9)。病例频率和发病率数据来源于SEER程序,用于设计本报告的表格格式和页数。结果。--在1973-2014年美国诊断的83658例癌症食管癌病例中,比较了年龄、性别、种族、分期、分级、队列进入时间、疾病持续时间和两种组织学肿瘤类型的多个变量。男性的平均年龄为66.5岁,女性为70.1岁,男性和女性均为67.2岁。85%以上的发病率发生在55-85岁以上的年龄段,男性在65-69岁(59.4%)达到高峰,女性在70-74岁(60.5%)达到高峰。从1975年到2014年,美国的总体年死亡率从每年每10万人3.69人略微上升到3.99人,超额死亡率仍然非常高。在83658例侵袭性病例中,82.6%为临床分期,79.4%为组织学分级。结论。——比较分析了相对频率、发病率和时间趋势,以及年龄、性别、种族、分期、分级、共病时间段和主要临床肿瘤类型的临床、人口统计学和长期变量,以提供1973-2014年时间框架内癌症生存率和死亡率的全面医学精算评估。
{"title":"20-Year Comparative Survival and Mortality of Cancer of the Esophagus by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 83,658 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4)","authors":"A. Milano","doi":"10.17849/insm-48-2-113-123.1","DOIUrl":"https://doi.org/10.17849/insm-48-2-113-123.1","url":null,"abstract":"Objective.— To update trends in incidence, prevalence, short- and long-term survival and mortality of esophageal cancer using the statistical database of SEER*Stat 8.3.4 for diagnosis years 1973-2014 employing multiple case selection variables.\u0000 Methods.— A retrospective, population-based study using nationally representative data from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) program to evaluate 83,658 cases of esophageal cancer for diagnosis years 1973-2014 comparing multiple variables of age, sex, race, stage, grade, cohort entry time-period, disease duration, and, two histologic oncotypes. Relative survival statistics were analyzed in two cohorts: 1973-1994 and 1995-2014. Survival statistics were derived from: SEER*Stat Database: Incidence – SEER 9 Regs Research Data, November 2016 Submission (1973-2014) <Katrina/Rita Population Adjustment> Released April 2017 (Ref. 9). Case frequency and incidence data, derived from the SEER program, were used to design the table format and number of pages for this report.\u0000 Results.— In a total of 83,658 cases of esophageal cancer in the United States for diagnosis years 1973-2014, multiple variables of age, sex, race, stage, grade, cohort entry time-period, disease duration, and, two histologic oncotypes were compared. Mean age in males was 66.5 years, females 70.1 years, both male and female 67.2 years. Greater than 85% of incidence cases occurred between ages 55-85+ years with the zenith in males at 65-69 years (59.4%) and 70-74 years (60.5%) in females. The overall annual US death rate from 1975-2014 has slightly increased from 3.69 to 3.99 per 100,000 per year, and excess mortality remains exceedingly high. Of the 83,658 invasive cases, 82.6% were clinically staged and 79.4% were histologically graded.\u0000 Conclusions.— Relative frequency, incidence and time-trends, and the clinical, demographic and secular variables of age, sex, race, stage, grade, cohort-entry time-periods, and predominant clinical oncotypes were comparatively analyzed to provide a comprehensive medical-actuarial assessment of esophageal cancer survival and mortality in the 1973-2014 time-frame.","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43261896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-based Claims Adjudication of Traffic Injury Claims in Ontario: Shifting the Focus from Cost to Care 安大略省交通伤害索赔的循证索赔裁决:将焦点从成本转移到护理
Q3 Medicine Pub Date : 2020-01-01 DOI: 10.17849/insm-48-2-1-11.1
K. Moodley, C. Cancelliere, R. Power, Pierre Côté
Background.— In the Ontario automobile insurance system, claims adjusters decide whether to approve, partially approve or deny funding for clinical interventions submitted by healthcare practitione...
背景。-在安大略省汽车保险系统中,索赔理算员决定是否批准、部分批准或拒绝医疗保健实践提交的临床干预资金。
{"title":"Evidence-based Claims Adjudication of Traffic Injury Claims in Ontario: Shifting the Focus from Cost to Care","authors":"K. Moodley, C. Cancelliere, R. Power, Pierre Côté","doi":"10.17849/insm-48-2-1-11.1","DOIUrl":"https://doi.org/10.17849/insm-48-2-1-11.1","url":null,"abstract":"Background.— In the Ontario automobile insurance system, claims adjusters decide whether to approve, partially approve or deny funding for clinical interventions submitted by healthcare practitione...","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67475740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hairy Cell Leukemia – A Mortality Analysis 毛细胞白血病-死亡率分析
Q3 Medicine Pub Date : 2020-01-01 DOI: 10.17849/INSM-48-2-136-143.1
Ahmed Okba
Objectives.—To assess mortality and survival analysis for patients with hairy cell leukemia, taking into consideration the effect of new therapies. Background.—Hairy cell leukemia (HCL) is a chroni...
目标。-考虑到新疗法的效果,评估毛细胞白血病患者的死亡率和生存分析。背景。毛细胞白血病(HCL)是一种慢性…
{"title":"Hairy Cell Leukemia – A Mortality Analysis","authors":"Ahmed Okba","doi":"10.17849/INSM-48-2-136-143.1","DOIUrl":"https://doi.org/10.17849/INSM-48-2-136-143.1","url":null,"abstract":"Objectives.—To assess mortality and survival analysis for patients with hairy cell leukemia, taking into consideration the effect of new therapies. Background.—Hairy cell leukemia (HCL) is a chroni...","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67475800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRISPR Technology Cracking into Creation CRISPR技术进入创造
Q3 Medicine Pub Date : 2020-01-01 DOI: 10.17849/INSM-48-2-144-148.1
Alacia J Tarpley
Medical directors of life and disability companies need to be aware of CRISPR technology and how it has beneficial and potential detrimental impacts to our industry. Clustered Interspaced Short Pal...
生命和残疾公司的医疗主管需要了解CRISPR技术,以及它如何对我们的行业产生有益和潜在的有害影响。群集间隔短朋友…
{"title":"CRISPR Technology Cracking into Creation","authors":"Alacia J Tarpley","doi":"10.17849/INSM-48-2-144-148.1","DOIUrl":"https://doi.org/10.17849/INSM-48-2-144-148.1","url":null,"abstract":"Medical directors of life and disability companies need to be aware of CRISPR technology and how it has beneficial and potential detrimental impacts to our industry. Clustered Interspaced Short Pal...","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67475811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of insurance medicine (New York, N.Y.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1